Skip to content
Screener

Generate Biomedicines, Inc. GENB Balance Sheet Statement

Q3 '26Q2 '26Q1 '26Q4 '25Q2 '25
$140.35M—$135.36M-12.3%$160.58M-27.2%$121.65M—$154.27M—
$263.86M—$322.06M—$356.07M—$99.85M———
$414.64M—$470.25M—$535.39M—$234.37M———
$38.65M—$27.31M—$27.84M—$29.15M———
$515.89M—$561.69M—$625.74M—$330.18M———
$7.89M—$5.65M—$7.62M+1,376%$3.84M———
$0—$0———$4.51M———
$12.5M—$3.74M———$4.31M———
$82.72M—$56.64M—$58.39M—$82.2M———
$134.73M—$105.65M—$110.94M—$141.55M———
$129K—$128K———$33K———
-$892.65M—-$804.99M—-$737.74M—-$676.29M———
$381.16M—$456.05M+188%$514.8M+209%-$615.97M-41.8%-$517.85M—
$515.89M—$561.69M—$625.74M—$330.18M———

FAQ

What are Generate Biomedicines, Inc.'s total assets?
Generate Biomedicines, Inc. (GENB) holds $515.9M in total assets.
How much debt does Generate Biomedicines, Inc. have?
Generate Biomedicines, Inc. carries $75.3M in total debt against $381.2M of shareholders' equity, a debt-to-equity ratio of 0.20.
How much cash does Generate Biomedicines, Inc. have?
Generate Biomedicines, Inc. holds $140.4M in cash and equivalents.
Can Generate Biomedicines, Inc. cover its short-term obligations?
Its current ratio is 5.01 — current assets exceed current liabilities.
Where does Generate Biomedicines, Inc.'s balance sheet data come from?
Every line is extracted from Generate Biomedicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.